相关实验视频
Updated: Jul 10, 2025

Measuring RAN Peptide Toxicity in C. elegans
Published on: April 30, 2020
RGMa破坏了神经元对疾病相关蛋白质的激素屏障,并加剧了ALS
Mikito Shimizu1, Naoyuki Shiraishi1, Satoru Tada1,2
1Department of Neurology, Neuroscience, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
排斥导向分子A (RGMa) 在肌缩侧硬化症 (ALS) 中升高. 用抗体向RGMa可以通过增强活性蛋白屏障来减少运动神经元中的疾病症状和蛋白质积累.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 病理学 病理学 病理学
背景情况:
- 排斥导向分子A (RGMa) 已知其在神经元发育中的作用.
- 对于RGMa与神经退行性疾病,如肌缩侧面硬化症 (ALS) 的相关性尚不清楚.
- Neogenin1 是已知的 RGMa 功能的调解者.
研究的目的:
- 调查RGMa在ALS病变发生中的作用.
- 为了确定是否准RGMa可以改善ALS症状.
主要方法:
- 测量了ALS患者和mSOD1小鼠脑脊液中的RGMa水平.
- 对mSOD1小鼠进行抗RGMa单克隆抗体的治疗.
- 进行了基因化学分析,以评估突变SOD1蛋白积累.
- 进行了体外研究,以评估抗体对细胞吸收的影响.
主要成果:
- 在ALS患者和mSOD1小鼠中,RGMa水平都升高.
- 反RGMa抗体治疗改善了mSOD1小鼠的临床症状.
- 该抗体通过抑制actin脱聚合,减少了运动神经元中的突变SOD1蛋白聚合.
- 在体外,该抗体通过加强神经元的活性蛋白屏障来阻止突变SOD1细胞吸收.
结论:
- RGMa通过导致神经元活性蛋白屏障崩和促进异常蛋白质沉积而加剧ALS病理.
- 用抗体向RGMa代表了ALS的潜在治疗策略.
更多相关视频
09:36Primary Cultures of Rat Astrocytes and Microglia and Their Use in the Study of Amyotrophic Lateral Sclerosis
Published on: June 23, 2022
06:54A Time-Efficient Fluorescence Spectroscopy-Based Assay for Evaluating Actin Polymerization Status in Rodent and Human Brain Tissues
Published on: June 3, 2021
相关概念视频
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Cross-bridge Cycle
GPCRs Regulate Adenylyl Cylase Activity
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Actin Filament Depolymerization
In F-actin, the ADF/cofilin proteins...